A Study of NB003 in Patients With Advanced Malignancies

PHASE1RecruitingINTERVENTIONAL
Enrollment

258

Participants

Timeline

Start Date

August 6, 2021

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions
Advanced Solid Tumor
Interventions
DRUG

NB003 tablets

NB003 tablets will be administered at assigned doses for escalation phase and RP2D doses for expansion phase orally twice daily for repeated 28-day cycles until discontinuation criteria are met.

Trial Locations (34)

11101

RECRUITING

Memorial Sloan Kettering Cancer Center, Long Island City

28040

RECRUITING

Hospital Universitario Fundacion Jimenez Diaz, Madrid

32224

RECRUITING

Standford University, Stanford

RECRUITING

Mayo Clinic, Jacksonville

69373

RECRUITING

Centre Léon Bérard, Lyon

77030

RECRUITING

U T MD Anderson Cancer Center Investigational Pharmacy Services, Houston

94805

RECRUITING

Institut Gustave Roussy, Villejuif

97239

RECRUITING

Oregon Health & Science University (OHSU), Portland

100142

RECRUITING

Beijing Cancer Hospital, Beijing

RECRUITING

Beijing Cancer Hospital, Beijing

100144

NOT_YET_RECRUITING

Peking University People's Hospital, Beijing

110042

RECRUITING

Liaoning Cancer Hospital & Institute, Shenyang

150081

RECRUITING

Harbin Medical University Cancer Hospital, Harbin

201315

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

RECRUITING

Renji Hospital Shanghai Jiaotong University School of Medicine - West Branch, Shanghai

210008

NOT_YET_RECRUITING

The Affiliated Hospital of Nanjing University Medical School, Nanjing

230601

RECRUITING

The Second Hospital of Anhui Medical University, Hefei

266003

RECRUITING

The Affiliated Hospital of Qingdao University, Qingdao

310003

RECRUITING

The First Affiliated Hospital of Zhejiang University school of medicine, Hangzhou

350015

NOT_YET_RECRUITING

Fujian Cancer Hospital, Fuzhou

400016

RECRUITING

The First Affiliated Hospital of Chongqing Medical University, Chongqing

410008

RECRUITING

Xiangya Hospital, Central South University, Changsha

430022

RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

453000

RECRUITING

Tianjin Medical University Cancer Institute & Hospital, Tianjin

510000

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

NOT_YET_RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

510080

RECRUITING

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

610041

RECRUITING

West China Hospital, Sichuan University, Chengdu

710004

NOT_YET_RECRUITING

The Second Affiliated Hospital of Xi'An Jiaotong University, Xi'an

02215

RECRUITING

Dana-Farber Cancer Institute, Boston

05505

RECRUITING

Asan Medical Center, Seoul

RECRUITING

Samsung Medical Center, Seoul

08035

RECRUITING

Hospital Universitari Vall d'Hebron, Barcelona

SW36JJ

RECRUITING

Royal Marsden Hospital-London, London

All Listed Sponsors
lead

Ningbo Newbay Technology Development Co., Ltd

INDUSTRY